Severe musculoskeletal syndrome in patients with renal failure and hypoalbuminemia receiving bumetanide.
Johnson
C A
CA
School of Pharmacy, University of Wisconsin-Madison 53706.
Grant
K L
KL
Madalon
M G
MG
D000328:Adult; D000368:Aged; D001847:Bone Diseases / Q000139:chemically induced*; D002034:Bumetanide / Q000009:adverse effects* / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects*; D004487:Edema / Q000188:drug therapy*; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*; D012709:Serum Albumin / Q000172:deficiency*
D004232:Diuretics; D012709:Serum Albumin; D002034:Bumetanide